Imx Ultrasentitive Htsh
510(k) K902753
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK902753 | Date10 Jul 1990 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- JLW
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.1690
- Advisory Committee
- Clinical Chemistry
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 28 Sep 2026
This device is a radioimmunoassay for thyroid-stimulating hormone (TSH) as defined in the device name and openfda specifications. It is designed to measure TSH levels in clinical chemistry settings.
The device received FDA 510(k) clearance under K902753 on July 10, 1990, and is classified as a Class II medical device. It is supplied for in vitro diagnostic use in clinical laboratories, with no indication of sterility, single-use status, or MRI safety provided in the data.
Other devices from Abbott Mfg., Inc.
Questions
AI-generated answers, 28 Sep 2026
What is the IMX ULTRASENTITIVE HTSH used for?
The IMX ULTRASENTITIVE HTSH is a radioimmunoassay designed to measure thyroid-stimulating hormone (TSH) levels in clinical chemistry settings. It is intended for in vitro diagnostic use to assess thyroid function by quantifying TSH in patient samples.
How is the IMX ULTRASENTITIVE HTSH supplied and is it sterile or single-use?
The device is supplied for in vitro diagnostic use in clinical laboratories. The provided data does not specify whether it is sterile, single-use, or reusable, so users should consult the manufacturer's labeling for details on handling, storage, and intended use format.
What regulatory clearance does the IMX ULTRASENTITIVE HTSH have?
The IMX ULTRASENTITIVE HTSH received FDA 510(k) clearance under submission K902753 on July 10, 1990. It is classified as a Class II medical device under regulation 862.1690 with product code JLW, and was determined to be substantially equivalent to a predicate device.